2019 Vault Rankings
“Getting to go to trial with wonderful colleagues”
“Quality of work and opportunities for associates”
“No billable hours”
“Very demanding pace”
“Unpredictability of hours”
“The intense pressure to do exceptional work”
Wilkinson Walsh is a high-stakes litigation firm headquartered in Washington, DC with offices in Los Angeles and New York City. The firm can count its age on one hand, but it’s hardly a fledgling—WW+E has soared from the start, achieving success after success in the courtroom. Within two months of its founding, the firm had already won its first major trial, defeating a $1.5 billion class action on behalf of Philip Morris.
The firm also eschews typical billing arrangements for options like flat rates and monthly retainers (thereby saving associates from the dreaded billable hour). Among the firm’s clients are such household names as Bayer, the NFL, Facebook, FedEx, George-Pacific, Pfizer, and the NCAA.
A 21st Century Firm
WW+E was founded in January 2016 to focus on winning high-stakes trials. Name partners Beth Wilkinson and Alexandra Walsh (formerly of Paul, Weiss) teamed up with Sean Eskovitz (a former Munger Tolles litigator), Brian Stekloff (formerly of Covington), and Brant Bishop (formerly of Kirkland & Ellis). The founding partners have collectively tried over 120 cases to verdict, and the firm’s senior attorneys include former federal prosecutors, a former federal public defender, former Supreme Court clerks, and an American Lawyer Litigator of the Year.
The firm isn’t just focused on winning cases, however. It prides itself in “developing the next generation of trial lawyers.” And that means getting on your feet. Since the firm’s founding, nearly a quarter of its attorneys have served as first or second chair at trial. And attorneys are actively encouraged to gain stand-up experience through pro bono matters.
Take Two and Win in the Morning
WW+E has shown what it’s made of in its representation of Bayer. The firm has won multiple trial victories for the pharmaceutical company, including defense verdicts in two federal-court and three state-court bellwether trials involving the blood-thinner Xarelto. Most recently, in September 2018, a jury needed only three hours to find that the Xarelto label had provided adequate instruction to doctors about bleeding risks. Sometimes WW+E works its magic post-trial—in 2017, the firm convinced a judge presiding over a Xarelto case in the Philadelphia Court of Common Pleas to set aside a multi-million dollar verdict for the plaintiff and instead rule in Bayer’s favor.
Small but Mighty Powerhouse
WW+E has received multiple accolades in its young life. Based on the firm’s success in just its first year, Benchmark Litigation named Wilkinson Walsh + Eskovitz the “Boutique Firm of the Year,” praising the firm as a “litigator’s dream shop.” Benchmark Litigation also awarded WW+E the National Impact Case Award for its role in winning summary judgment for Georgia-Pacific in an antitrust class action lawsuit that involved more than $10 billion in claimed damages. Firm attorneys have also amassed a variety of honors. Name partner and founder, Beth Wilkinson, was named Trial Lawyer of the Year for 2018 by Benchmark Litigation. And the WW+E crew has been recognized by Benchmark Litigation’s “40 & Under Hot List,” Benchmark Litigation’s “Top 250 Women in Litigation,” The American Lawyer’s “Litigator of the Week,” Law360’s “Rising Stars,” and Law360’s Legal Lions.
2001 M Street, NW
Washington, DC 20036
Phone: (202) 847-4000
Managing Partner: Brant W. Bishop
Hiring Partner: Brian Stekloff
Total No. Attorneys 2018: 45
Washington, DC (HQ)
Los Angeles, CA
New York, NY